Found: 2

Select item for more details and to access through your institution.

  • Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain.

    Published in:
    Pediatric Allergy & Immunology, 2023, v. 34, n. 4, p. 1, doi. 10.1111/pai.13942
    By:
    • Nieto‐Cid, María;
    • Garriga‐Baraut, Teresa;
    • Plaza‐Martín, Ana Mª.;
    • Tortajada‐Girbés, Miguel;
    • Torres‐Borrego, Javier;
    • Lozano‐Blasco, Jaime;
    • Moreno‐Galarraga, Laura;
    • del Mar Folqué‐Giménez, Mª.;
    • Bosque‐García, Montse;
    • Gaboli, Mirella;
    • López‐Neyra, Alejandro;
    • Rivas‐Juesas, Cristina;
    • Caballero‐Rabasco, Mª. Araceli;
    • Freixa‐Benavente, Andrea;
    • Valdesoiro‐Navarrete, Laura;
    • de Mir‐Messa, Inés;
    • Ballester‐Asensio, Esther;
    • Penín‐Antón, María;
    • Romero‐García, Raquel;
    • Navarro‐Morón, Juan
    Publication type:
    Article

  • Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma.

    Published in:
    Pediatric Allergy & Immunology, 2021, v. 32, n. 5, p. 980, doi. 10.1111/pai.13484
    By:
    • Nieto García, Antonio;
    • Garriga‐Baraut, Teresa;
    • Plaza Martín, Ana María;
    • Nieto Cid, María;
    • Torres Borrego, Javier;
    • Folqué Giménez, María del Mar;
    • Lozano Blasco, Jaime;
    • Bosque García, Montserrat;
    • Moreno‐Galarraga, Laura;
    • Tortajada‐Girbés, Miguel;
    • Rivas Juesas, Cristina;
    • Penín Antón, María;
    • Caballero‐Rabasco, María Araceli;
    • Gaboli, Mirella;
    • López Neyra, Alejandro;
    • Navarro Morón, Juan;
    • Freixa Benavente, Andrea;
    • Valdesoiro Navarrete, Laura;
    • Ballester Asensio, Esther;
    • Sanz Santiago, Verónica
    Publication type:
    Article